AlloVir
Developing cellular immunotherapies for severe viral infections. Learn more
Launch date
Employees
Market cap
$86.8m
Enterprise valuation
($34m) (Public information from Sep 2024)
Share price
$0.79 ALVR
Lincoln Massachusetts (HQ)
Authorizing premium user...